Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1601-1608
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1601
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1601
Before (n = 51) | After (n = 51) | t | P value | |
ALT (U/L) | 75.11 ± 4.62 | 60.62 ± 4.09 | 16.771 | 0 |
AST (U/L) | 119.47 ± 11.69 | 41.57 ± 6.88 | 41.013 | 0 |
LDH (U/L) | 439.15 ± 20.62 | 236.73 ± 18.15 | 52.623 | 0 |
AFP-13 (%) | 18.52 ± 5.37 | 11.31 ± 2.65 | 8.598 | 0 |
- Citation: Wang GF, Shu CX, Cai XD, Wang HB, Xu JH, Jia YQ. Clinical efficacy of Gamma Knife® combined with transarterial chemoembolization and immunotherapy in the treatment of primary liver cancer. World J Gastrointest Surg 2024; 16(6): 1601-1608
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1601.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1601